Huber, L., Birk, R., Knüttel, M. T., Rotter, N., Aderhold, M. C., Scherl, C., . . . Kramer, B. (2022). Targeted treatment of HPV16-positive and -negative SCC cells with small molecule tyrosine kinase inhibitors and everolimus affects MMP2 and MMP14 expression. Anticancer research, 42(7), . https://doi.org/10.21873/anticanres.15827
Chicago-Zitierstil (17. Ausg.)Huber, Lena, Richard Birk, Manuel Thomas Knüttel, Nicole Rotter, Marc Christoph Aderhold, Claudia Scherl, Anne Lammert, Frederic Jungbauer, und Benedikt Kramer. "Targeted Treatment of HPV16-positive and -negative SCC Cells with Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression." Anticancer Research 42, no. 7 (2022). https://doi.org/10.21873/anticanres.15827.
MLA-Zitierstil (9. Ausg.)Huber, Lena, et al. "Targeted Treatment of HPV16-positive and -negative SCC Cells with Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression." Anticancer Research, vol. 42, no. 7, 2022, https://doi.org/10.21873/anticanres.15827.